Whitehawk Therapeutics, INC. (WHWK) — DEF 14A Filings
All DEF 14A filings from Whitehawk Therapeutics, INC.. Browse 2 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (2)
-
Whitehawk Therapeutics DEF 14A: Executive Pay & Governance
— Apr 28, 2025 Risk: medium
Whitehawk Therapeutics, Inc. (formerly Aadi Bioscience, Inc.) filed its DEF 14A on April 28, 2025, detailing executive compensation and corporate governance mat -
Aadi Bioscience, Inc. Files Definitive Proxy Statement
— Apr 26, 2024 Risk: low
Aadi Bioscience, Inc. (WHWK) filed a Proxy Statement (DEF 14A) with the SEC on April 26, 2024. Aadi Bioscience, Inc. filed a Definitive Proxy Statement (DEF 14A
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX